Continental Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,512
| Closed | -$355K | – | 59 |
|
|
2022
Q2 | $355K | Hold |
9,512
| – | – | 0.21% | 58 |
|
|
2022
Q1 | $421K | Hold |
9,512
| – | – | 0.21% | 55 |
|
|
2021
Q4 | $404K | Sell |
9,512
-1,130
| -11% | -$47.5K | 0.17% | 61 |
|
|
2021
Q3 | $462K | Sell |
10,642
-1,110
| -9% | -$49.1K | 0.2% | 63 |
|
|
2021
Q2 | $503K | Sell |
11,752
-2,300
| -16% | -$96.8K | 0.23% | 56 |
|
|
2021
Q1 | $543K | Hold |
14,052
| – | – | 0.25% | 66 |
|
|
2020
Q4 | $505K | Hold |
14,052
| – | – | 0.23% | 67 |
|
|
2020
Q3 | $537K | Sell |
14,052
-2,900
| -17% | -$112K | 0.28% | 74 |
|
|
2020
Q2 | $595K | Hold |
16,952
| – | – | 0.32% | 69 |
|
|
2020
Q1 | $553K | Hold |
16,952
| – | – | 0.41% | 67 |
|
|
2019
Q4 | $767K | Sell |
16,952
-5,651
| -25% | -$236K | 0.37% | 63 |
|
|
2019
Q3 | $920K | Sell |
22,603
-1,404
| -6% | -$59.5K | 0.54% | 57 |
|
|
2019
Q2 | $1.03M | Sell |
24,007
-3,500
| -13% | -$135K | 0.58% | 57 |
|
|
2019
Q1 | $1.06M | Sell |
27,507
-29,593
| -52% | -$1.13M | 0.49% | 64 |
|
|
2018
Q4 | $2.02M | Hold |
57,100
| – | – | 0.62% | 63 |
|
|
2018
Q3 | $2.2M | Hold |
57,100
| – | – | 0.48% | 66 |
|
|
2018
Q2 | $1.87M | Hold |
57,100
| – | – | 0.47% | 67 |
|
|
2018
Q1 | $1.56M | Hold |
57,100
| – | – | 0.4% | 70 |
|
|
2017
Q4 | $1.42M | Sell |
57,100
-10,000
| -15% | -$276K | 0.31% | 78 |
|
|
2017
Q3 | $1.96M | Hold |
67,100
| – | – | 0.45% | 65 |
|
|
2017
Q2 | $1.86M | Sell |
67,100
-37,500
| -36% | -$995K | 0.42% | 72 |
|
|
2017
Q1 | $2.6M | Sell |
104,600
-35,000
| -25% | -$851K | 0.58% | 55 |
|
|
2016
Q4 | $3.02M | Hold |
139,600
| – | – | 0.82% | 36 |
|
|
2016
Q3 | $3.32M | Hold |
139,600
| – | – | 0.93% | 36 |
|
|
2016
Q2 | $3.26M | Sell |
139,600
-30,000
| -18% | -$649K | 1.01% | 33 |
|
|
2016
Q1 | $3.19M | Hold |
169,600
| – | – | 0.9% | 35 |
|
|
2015
Q4 | $3.13M | Hold |
169,600
| – | – | 0.79% | 39 |
|
|
2015
Q3 | $2.78M | Hold |
169,600
| – | – | 0.75% | 51 |
|
|
2015
Q2 | $3M | Sell |
169,600
-10,000
| -6% | -$179K | 0.8% | 46 |
|
|
2015
Q1 | $3.19M | Hold |
179,600
| – | – | 0.7% | 51 |
|
|
2014
Q4 | $2.38M | Hold |
179,600
| – | – | 0.48% | 66 |
|
|
2014
Q3 | $2.12M | Hold |
179,600
| – | – | 0.48% | 62 |
|
|
2014
Q2 | $2.29M | Hold |
179,600
| – | – | 0.53% | 53 |
|
|
2014
Q1 | $2.43M | Sell |
179,600
-25,300
| -12% | -$332K | 0.63% | 48 |
|
|
2013
Q4 | $2.46M | Sell |
204,900
-14,700
| -7% | -$174K | 0.54% | 54 |
|
|
2013
Q3 | $2.58M | Sell |
219,600
-108,200
| -33% | -$1.17M | 0.64% | 46 |
|
|
2013
Q2 | $3.04M | Buy |
+327,800
| New | +$2.78M | 0.86% | 37 |
|
Other funds holding BSX
BG
Continental Advisors's BSX Position: Q3 2022 in Review
Continental Advisors sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 9,512 shares — an estimated $355K sold.
Continental Advisors first reported a position in BSX in Q2 2013 and held it in 37 quarters. The position peaked at $3.32M in Q3 2016. 866 funds tracked by Wall St. Rank hold BSX as of Q3 2022.
- Continental Advisors reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
- Continental Advisors sold 9,512 Boston Scientific shares in Q3 2022, an estimated $355K.
- Continental Advisors first reported a position in Boston Scientific in Q2 2013 and held it in 37 quarters.
- Continental Advisors's Boston Scientific position peaked at $3.32M in Q3 2016.
- 866 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.
Based on Continental Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.